Fundraising Fox
Diagonaltx
Watertown, US · Founded 2022 · 38 employees on LinkedIn · 5 known investors
Find your way into Diagonaltx
Diagonal Therapeutics develops multi-specific clustering antibody therapeutics that bind multiple cell-surface receptors to activate or inhibit dysregulated signaling pathways underlying chronic diseases. Its DIAGONAL Product Engine uses computational and experimental methods to identify clustering antibodies across receptor classes, with a lead candidate (DIAG723) in a Phase 1/2 trial for Hereditary Hemorrhagic Telangiectasia.
Investors · 5
How we know: Atlas Venture's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Diagonaltx do?
- Diagonal Therapeutics develops multi-specific clustering antibody therapeutics that bind multiple cell-surface receptors to activate or inhibit dysregulated signaling pathways underlying chronic diseases. Its DIAGONAL Product Engine uses computational and experimental methods to identify clustering antibodies across receptor classes, with a lead candidate (DIAG723) in a Phase 1/2 trial for Hereditary Hemorrhagic Telangiectasia.
- Who are Diagonaltx's investors?
- Diagonaltx's investors include Atlas Venture, EcoR1 Capital, Frazier Life Sciences, RA Capital, Sanofi Ventures.
- Where is Diagonaltx headquartered?
- Diagonaltx is headquartered in Watertown, US.